Acetazolamide in Decompensated Heart Failure with Volume Overload trial (ADVOR): baseline characteristics.
Mullens W, Dauw J, Martens P, Meekers E, Nijst P, Verbrugge FH, Chenot F, Moubayed S, Dierckx R, Blouard P, Derthoo D, Smolders W, Ector B, Hulselmans M, Lochy S, Raes D, Van Craenenbroeck E, Vandekerckhove H, Hofkens PJ, Goossens K, Pouleur AC, De Ceuninck M, Gabriel L, Timmermans P, Prihadi EA, Van Durme F, Depauw M, Vervloet D, Viaene E, Vachiery JL, Tartaglia K, Ter Maaten JM, Bruckers L, Droogne W, Troisfontaines P, Damman K, Lassus J, Mebazaa A, Filippatos G, Ruschitzka F, Dupont M.
Mullens W, et al. Among authors: vervloet d.
Eur J Heart Fail. 2022 Sep;24(9):1601-1610. doi: 10.1002/ejhf.2587. Epub 2022 Jul 12.
Eur J Heart Fail. 2022.
PMID: 35733283
Free article.
Clinical Trial.